Transapical transcatheter aortic valve implantation in a high-risk patient with aortic and mitral regurgitation: usage of the JenaValve™ system

JenaValve(TM)system is a second-generation transcatheter heart valve that provides a successful deployment not only in calcified stenotic aortic valves but also in non-calcified, severe regurgitant aortic valves. We performed a transapical transcatheter aortic valve implantation procedure using this...

Full description

Saved in:
Bibliographic Details
Published inThe European research journal Vol. 2; no. 3; p. 219
Main Authors Surer, Suleyman, Ince, Ilker, Duvan, Ibrahim, Bayyurt, Cengizhan, Kiziltepe, Ugursay
Format Journal Article
LanguageEnglish
Published Bursa The Association of Health Research & Strategy 08.09.2016
Online AccessGet full text

Cover

More Information
Summary:JenaValve(TM)system is a second-generation transcatheter heart valve that provides a successful deployment not only in calcified stenotic aortic valves but also in non-calcified, severe regurgitant aortic valves. We performed a transapical transcatheter aortic valve implantation procedure using this system without any procedure-related complications in a 75-year-old woman with multiple co-morbidity factors, who had both mitral and aortic regurgitation, and low ejection fraction.
ISSN:2149-3189
2149-3189
DOI:10.18621/eurj.2016.5000197998